MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
1-Year Return
46.22%
This Quarter Return
-13.07%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$10.3B
AUM Growth
-$4.23B
(-29%)
Cap. Flow
-$2.31B
Cap. Flow
% of AUM
-22.32%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
1,775
New
890
Increased
241
Reduced
317
Closed
326
Top Buys
| 1 |
Comcast
CMCSA
|
$130M |
| 2 |
PayPal
PYPL
|
$92.3M |
| 3 |
Becton Dickinson
BDX
|
$78.9M |
| 4 |
Honeywell
HON
|
$72.1M |
| 5 |
Nike
NKE
|
$64.5M |
Top Sells
| 1 |
Equifax
EFX
|
$169M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$166M |
| 3 |
Cigna
CI
|
$159M |
| 4 |
Microsoft
MSFT
|
$154M |
| 5 |
Global Payments
GPN
|
$145M |
Sector Composition
| 1 | Healthcare | 29.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 11.05% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
3M
MMM
$82.7B
| $5.87M | 0.06% |
+36,854
| New | +$5.87M |
|
227
Ovintiv
OVV
$10.6B
| $5.86M | 0.06% |
202,810
+178,197
| +724% | +$5.15M |
|
|
KL
228
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $5.81M | 0.06% |
222,867
+152,308
| +216% | +$3.97M |
|
229
Jazz Pharmaceuticals
JAZZ
$7.86B
| $5.79M | 0.06% |
+46,707
| New | +$5.79M |
|
230
EnerSys
ENS
$3.89B
| $5.71M | 0.06% |
73,575
+68,768
| +1,431% | +$5.34M |
|
231
Verisk Analytics
VRSK
$37.8B
| $5.69M | 0.06% |
+52,148
| New | +$5.69M |
|
232
East-West Bancorp
EWBC
$14.8B
| $5.65M | 0.05% |
129,909
+108,348
| +503% | +$4.72M |
|
233
D.R. Horton
DHI
$54.2B
| $5.63M | 0.05% |
+162,373
| New | +$5.63M |
|
234
Viper Energy
VNOM
$6.29B
| $5.61M | 0.05% |
215,409
+141,356
| +191% | +$3.68M |
|
235
Mettler-Toledo International
MTD
$26.9B
| $5.59M | 0.05% |
+9,883
| New | +$5.59M |
|
|
MNDT
236
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $5.59M | 0.05% |
344,826
-130,876
| -28% | -$2.12M |
|
237
DuPont de Nemours
DD
$32.6B
| $5.56M | 0.05% |
51,487
+8,745
| +20% | +$944K |
|
238
Supernus Pharmaceuticals
SUPN
$2.58B
| $5.5M | 0.05% |
+165,413
| New | +$5.5M |
|
239
Albemarle
ALB
$9.6B
| $5.46M | 0.05% |
70,871
+17,880
| +34% | +$1.38M |
|
240
Conagra Brands
CAG
$9.23B
| $5.46M | 0.05% |
255,605
-280,566
| -52% | -$5.99M |
|
241
Best Buy
BBY
$16.1B
| $5.31M | 0.05% |
100,258
-29,016
| -22% | -$1.54M |
|
|
NXTM
242
DELISTED
NxStage Medical Inc.
NXTM
| $5.29M | 0.05% |
+184,953
| New | +$5.29M |
|
243
Sun Communities
SUI
$16.2B
| $5.19M | 0.05% |
51,020
+31,773
| +165% | +$3.23M |
|
244
Veeva Systems
VEEV
$44.7B
| $5.19M | 0.05% |
58,078
+53,678
| +1,220% | +$4.79M |
|
245
New Oriental
EDU
$7.98B
| $5.07M | 0.05% |
92,479
-87,913
| -49% | -$4.82M |
|
246
Truist Financial
TFC
$60B
| $5.04M | 0.05% |
+116,228
| New | +$5.04M |
|
|
GRA
247
DELISTED
W.R. Grace & Co.
GRA
| $5.01M | 0.05% |
+77,109
| New | +$5.01M |
|
248
Crocs
CROX
$4.72B
| $5M | 0.05% |
+192,323
| New | +$5M |
|
249
CSX Corp
CSX
$60.6B
| $4.93M | 0.05% |
238,239
+19,179
| +9% | +$397K |
|
|
CLVS
250
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.9M | 0.05% |
272,991
+224,331
| +461% | +$4.03M |
|